For Rudranil Sinha’s parents, everything was normal until their two-year-old son suddenly became very unwell. He developed high fever and other health problems, and after tests in West Bengal, the family received devastating news — Rudranil had hepatoblastoma, a form of liver cancer.
Doctors referred him to AIG Hospitals, Hyderabad, for specialized treatment. His scans showed multiple tumors in the right side of his liver, with the largest measuring around 11.6 cm.
Rudranil is the younger of two siblings. His father used to work at a cyber café in West Bengal, earning around ₹6,000–₹7,000 a month, but is currently unable to work because of his son’s treatment.
Leaving West Bengal for Hyderabad was not easy for the family, but they had no choice. They used their savings, came to Hyderabad, rented a room and began managing Rudranil’s treatment and daily expenses with whatever little they had. They have even sold the small piece of land they owned, but it still isn’t enough.
His Treatment Is Still Going On
Rudranil has already completed two cycles of chemotherapy and, according to his mother, doctors have advised another 2–3 cycles before moving ahead with surgery.
A Right Hepatectomy is planned to remove the affected portion of his liver. The hospital has estimated the treatment and hospitalization cost at around ₹5.60 lakh, apart from possible additional expenses.
For a family with no regular income left, arranging this amount is beyond their means.
Rudranil is only two years old. His parents have already given everything they could to keep his treatment going.
Now, they are reaching out for help so their little boy can complete his treatment and have a chance to return home healthy.
Your support can help Rudranil continue his chemotherapy and move closer to the surgery he needs.
Please help this little boy fight cancer and get the chance to grow up with his family.
🗓️ September 17, 2026: The doctors have advised regular blood tests and follow-up on September 18, after which Rudranil is scheduled to be readmitted on September 19 for his next cycle of chemotherapy.
🗓️ September 19, 2026:
Rudranil has completed his 3rd cycle of day-care chemotherapy at AIG Hospitals, Hyderabad, as per the prescribed treatment protocol (SuperPLADO – Cisplatin).
He received Cisplatin chemotherapy along with hydration and supportive medicines. After completing the cycle, he was discharged in stable condition with medicines for the next few days.
The doctors have advised a mid-cycle evaluation on September 28, including CBP, RFT and other required blood tests, to monitor his progress and plan the next stage of treatment. Rudranil continues his treatment under medical supervision.
🗓️ September 28, 2026:
Rudranil had his follow-up consultation today with his oncologist. The doctor has advised CBC, RFT and LFT tests as part of his ongoing treatment monitoring.
His next review has been scheduled for October 9, 2026, and his next chemotherapy cycle is expected to begin around October 10, 2026, subject to his reports and medical condition.
🗓️ October 09, 2026: We would like to share that Rudranil underwent all his required tests today as part of his ongoing treatment. His next chemotherapy session is scheduled for tomorrow, October 10, 2026, at AIG Hospitals, Hyderabad. The medical team will continue to monitor his condition and guide the next steps in his treatment.
🗓️ October 10, 2026:
We are sharing an update that Rudranil has been admitted to AIG Hospitals, Hyderabad, today for his next chemotherapy session.
We request your continued prayers and support for Rudranil as he continues his fight against cancer. Every bit of support brings hope and strength to him and his family during this challenging time.
by Jan Sanjeevni Trust
by Jan Sanjeevni Trust
by Jan Sanjeevni Trust
by Jan Sanjeevni Trust
